您的位置: 首页 > 农业专利 > 详情页

NOUVEAU COMPOSÉ 1,2,4-TRIAZINE DISUBSTITUÉ
专利权人:
Mitsubishi Tanabe Pharma Corporation
发明人:
申请号:
EP15782458.2
公开号:
EP3135668B1
申请日:
2015.04.23
申请国别(地区):
EP
年份:
2019
代理人:
摘要:
This invention provides a novel disubstituted 1,2,4-triazine compound or a pharmaceutically acceptable salt thereof, which has an aldosterone synthetase inhibitory activity and is useful for preventing and/or treating various diseases or conditions associated with aldosterone; a method for preparing it; use of it; as well as a pharmaceutical composition comprising it as an active ingredient. A compound of the general formula [I]: wherein R A is, for example, a group of the following formula (A-1): wherein ring A 1 is, for example, a cycloalkyl group which may be substituted, and R B is, for example, a monocyclic cycloalkyl group, or a pharmaceutically acceptable salt thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充